Abbott net sales up in Q2
Abbott‘s net earnings were $1.94bn, compared to $1.29bn for the same period in the prior year. The company’s operating earnings was $1.77bn for the second quarter ended 30

Abbott‘s net earnings were $1.94bn, compared to $1.29bn for the same period in the prior year. The company’s operating earnings was $1.77bn for the second quarter ended 30

The expansion of Stouffville plant and equipment deployment will allow Teva Canada to produce one billion more tablets of prescription based generic medicines per year. Further, the expansion

Currently, Pfizer has 11% ownership of Icagen’s fully diluted shares. Pfizer expects to purchase the remaining 8.3m shares at $6 per share. In 2007, Pfizer and Icagen joined

The company’s Oxymorphone Hydrochloride ER tablets, CII are the generic version of Opana ER. Opana ER is indicated for the relief of moderate to severe pain in patients

Brilinta is indicated to reduce unstable angina, non-ST-elevation myocardial infarction or ST-elevation myocardial infarction in patients with ACS. The FDA approval was given on the basis of the

AHM is a supplier of speaker program and commercial compliance management solutions for the pharmaceutical industry. Prior to joining AHM, Burgess was the president and CEO of Healthland.

As per the terms of the agreement, both the parties will jointly work to educate patients and physicians on hepatitis C virus (HCV) in Europe, Asia and Latin

Following the acquisition, Astex has become a wholly owned subsidiary of SuperGen. SuperGen plans to re-brand Astex Therapeutics as Astex Pharmaceuticals in the third quarter of 2011. The

With this discovery, GSK has paid preclinical milestone to Regulus. The agreement between the companies aims to discover and develop compounds targeting four different microRNAs in inflammation and

Anomatic is a diversified manufacturer of anodized aluminum packaging for the pharmaceutical, medical, cosmetic and health & beauty packaging industries worldwide. The company plans to establish a 65,000